Point of Care Testing Market Analysis On Competitive Landscape 2019 By Johnson & Johnson, BD, Beckman Coulter, Siemens, Roche, Abbott, Alere Inc., Medtronic, Medica Corporation

The global point-of-care testing market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

This report contains all the company profiles of the key players and brands that making moves such as developments, product launches, joint ventures, merges and accusations which affect the Point-of-Care Testing (POCT) market, along with the company profiles the report also contains the market restrains and drivers which are derived through SWOT analysis of the Point-of-Care Testing market.

The report also gives an in-depth idea about what the market definition, classifications, applications and market trends are, the report also contains the CAGR figures for the historic year 2016 base year 2017 and forecast year 2018-2024.

Request for sample copy of this report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market

Market Drivers:

Some of the major factors driving the market for Point-Of-Care Testing Market, such as increasing geriatric population, increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others), technological advancements, introduction of home-based point of care devices, and rapid economic development in the emerging economies. These factors such as increased awareness among the population, ease of use, rapid test, right dosage to the right place, and enhanced patient compliance are also driving the growth for the point-of-care testing market.

Growing Geriatric Population: Global Point-of-Care Testing Market

Improved economic growth, better healthcare, and growthin access to education have led to longer life expectancy in most socio-economic groups. Due to growing geriatric population, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, infections, cardiometabolic risks and cancer. The normal aging process causes a variety of physical and emotional issues that can be difficult for both the geriatric patient and healthcare worker to understand their needs and be sensitive in their treatment

Advancement In Technology : Global Point-of-Care Testing Market

POCT technologies are evolving, and this market segment is growing at a rapid pace. The use of POCT has evolved further since 2013, with high range of professional and self-monitoring tests into the ambulatory setting with a patient centric focus.. The need to improve patient safety and outcomes through rapid testing with trustworthy and actionable results at the point of care has provided significant benefits, including the ability to provide immediate and appropriate medical intervention. A continuous effort and progress has been made by manufacturers to create products with newer, advanced technologies with reduced sample volume or less blood on portable devices

Questions? We’ll Put You On The Right Path Request Analyst Call for Global Point-of-Care Testing (POCT) Market Report Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=point-care-testing-poct-market

Decentralized Laboratory Testing : Global Point-of-Care Testing Market

For decentralized lab testing, there are two drivers i.e., need for better drug monitoring for diseases like cancer and increasing virulence of infectious diseases. Molecular testing for hospital acquired infections has risen over the last several years so as to reduce cost and length of stay (LOS). Most of the molecular diagnostic tests are carried out in large reference lab or in CLIA-accredited labs but due to more availability of molecular diagnostic tests (specifically for conditions giving a quick result) decentralized labs ora push towards decentralized testing and near-patient settings are seen as a feasible and growing market

HOFFMANN-LA ROCHE LTD:

Historical Background – Roche was established in 1896

Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.
Main focus: Since the establishment in 1896, the company’s main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.
Main Business Areas: Pharmaceuticals and Diagnostics.

Recent Developments:

1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes

2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.

3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.

Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.